Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Endosomal trafficking genes refer to a broad category of genes involved in the regulation of the endocytic pathway, which manages the internalization, sorting, recycling, and degradation of proteins and lipids within cells. This group includes various protein families such as the RAB GTPases, the sorting nexins (SNX), and the vacuolar protein sorting (VPS) complexes (e.g., the Retromer complex). These genes play critical roles in cellular homeostasis by controlling the distribution of signaling receptors and the clearance of waste products. Dysregulation of endosomal trafficking is a hallmark of several pathologies, most notably Alzheimer's disease, where genes like SORL1, BIN1, and CD2AP are implicated in the faulty processing of amyloid precursor protein (APP). While individual components of this system are being explored as therapeutic targets, 'Endosomal trafficking genes' as a collective term describes a functional pathway rather than a single druggable entity.
Not applicable as this is a gene category rather than a single target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Endosomal trafficking genes (ETG).